Gilead Sciences (GILD) FCF Payout Ratio (2009 - 2026)

Gilead Sciences (GILD) has reported FCF Payout Ratio for 13 consecutive years, with 0.3 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, FCF Payout Ratio fell 78.31% year-over-year to 0.3; the trailing twelve-month figure through Jun 2026 stood at 0.31 (down 25.73% YoY), and the FY2025 full-year result was 0.42, up 11.34% from the prior year.
• FCF Payout Ratio declined to 0.3 in Q2 2026 per GILD's latest filing, from 0.43 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 1.38 in Q2 2025 and bottomed at 0.23 in Q3 2024.
• Historically, FCF Payout Ratio has averaged 0.51 across 5 years, with a median of 0.45 in 2023.
• The sharpest annual moves came in 2024 and 2026: FCF Payout Ratio surged 88.65% in 2024, then sank 78.31% in 2026.
• Over 5 years, FCF Payout Ratio stood at 0.39 in 2022, then rose by 24.74% to 0.49 in 2023, then slipped by 29.08% to 0.34 in 2024, then dropped by 7.46% to 0.32 in 2025, then retreated by 5.67% to 0.3 in 2026.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.3, 0.43, and 0.32 for Q2 2026, Q1 2026, and Q4 2025 respectively.